• Welcome to Specialised Therapeutics

Q&A: Catching Up On Key Concepts

image_pdfimage_print

 

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

 

Timing Question
00:01:15
  1. After STRASS 1, the preoperative versus no preoperative radiotherapy for primary retroperitoneal sarcoma, the first-line treatment per the results of this trial is
00:04:30
  1. According to the global, Europe, Asia, America, Consensus-Based Guideline 2020 for desmoid fibromatosis, the first-line strategy of managing a desmoid, apart from any patient with a complication is?
00:07:25
  1. What is the main clinical feature of BCOR rearranged sarcomas?
00:09:33
  1. What of the following statements is correct (with reference to WHO classification)?
00:12:55
  1. Avapritinib was approved in 2020 for what type of sarcoma?
00:14:27
  1. Which of the following is false about NTRK fusions?

 

[video_lightbox_youtube video_id=”-TzWTZNfFeg&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]

Click Here To Open Transcript

Tags: , ,